The Hippo pathway promotes platinum-based chemotherapy by inhibiting MTF1-dependent heavy metal response
Abstract The platinum-based compounds are widely used in treating various types of cancer through their heavy metal component platinum. However, the development of chemoresistance often limits their clinical effectiveness. In this study, we report the roles of heavy metal response and its associated...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-13661-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|